siRNA, Anti-WDR33, 2'-F/2'-OMe/2'-MOE/LNA/Ribo/Backbone-modified(CAT#: SIRGT41691WQ-2OMe)

The product SIRGT41691WQ-2OMe is a type of small interfering RNA (siRNA) that targets WDR33 gene and regulates the expression of gene. The siRNA interferes with the expression of WDR33 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_001006622.2
Alternative Names NET14; WDC146
Related Diseases Atrial Septal Defect 6
Purification HPLC
Target Gene
Gene ID 55339
Uniprot ID Q9C0J8
Sub Cat Target Species Modification Scale  
SIRGT42691WQ-2F WDR33 Human 2ʹ-deoxy-2ʹ-fluoro (2'-F) Inquiry
SIRGT43691WQ-2MOE WDR33 Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT44691WQ-LNA WDR33 Human Locked Nucleic Acid (LNA) Inquiry
SIRGT41691WQ-RB WDR33 Human Ribo-modified Inquiry
SIRGT42691WQ-BB WDR33 Human Backbone-modified Inquiry

Related Products